¿´Æ¬ÊÓÆµ

Object moved to here.

¿´Æ¬ÊÓÆµ :: Pilot & Feasibility Program Application

¿´Æ¬ÊÓÆµ


Comparative Transcriptomics to Identify Key Gene Networks of Diabetic Neuropathy
Summary Data Summary
Applicant Hur, Junguk
E-Mail Address junguk.hur@med.und.edu
Project Title Comparative Transcriptomics to Identify Key Gene Networks of Diabetic Neuropathy
CBU ID 15GHSU2517
External SubContract ID 25034-75
Diabetic Complication Neuropathy & Neurocognition
Funding Program Group Pilot & Feasibility [PF2015]
Abstract Diabetes currently affects 29 million Americans, and the incidence is increasing
by 5% per year. Diabetic peripheral neuropathy (DPN), the most common
complication of diabetes, occurs in approximately 60% of all diabetic subjects.
DPN is the leading cause of diabetes-related hospital admissions and
non-traumatic amputations in the United States, there is substantial irreparable
nerve damage prior to the development of noticeable symptoms. However, there are
currently no disease-modifying treatments available for DPN other than glycemic
control and symptomatic treatments for pain. Therefore, there is a critical need
to identify novel effective therapies for DPN. The overall objectives of this
proposal is (1) to identify crucial genes and pathways that underlie the
progression of human DPN, and (2) to identify commonly dysregulated critical
pathways in both human DPN and animal models of DPN. The rationale for the
proposed research is that the identification of shared critical pathways and
gene expression signatures between human and mouse DPN will elucidate the core
mechanisms of DPN progression and expedite the development of mechanism-based
therapeutic agents. We will accomplish the objectives of this proposal by
pursuing the following specific aims: Aim 1. Identify dysregulated genes and
pathways in human DPN using RNA-Seq. We previously reported that there are
distinctive groups of human subjects with regenerative, stable, or degenerative
DPN. We will use RNA-Seq to compare the transcriptomic signatures in sural
nerves biopsies from subjects with regenerative DPN to subjects with
degenerative DPN. Aim 2. Identify commonly dysregulated DPN-associated genes and
pathways across species. We will compare the transcriptional regulatory network
in human DPN with those identified in various mouse DPN models to provide
insight into common pathways underlying DPN across species. We anticipate that
the key genes and pathways highly correlated with DPN progression and conserved
across species will play crucial roles in the pathogenesis of DPN and serve as
primary targets of therapeutic intervention of DPN.
Application PDF Application Research Plan
Status Contract Executed
Key Personnel
Salary Total Costs 29442
Supply Total Costs 1847
Equipment Total Costs 0
Travel/Other Total Costs 40500
Direct Costs 71789
Indirect Costs Proposed 27697
Total Costs Proposed 99486
Total Costs Approved 89537
Start Date 10/1/2015
End Date 1/31/2017
IFO Name Horner, Sally
IFO E-Mail Address sally.horner@research.und.edu
IACUC/IRB No. 99999
IACUC/IRB Institution University of North Dakota
Entity ID No.
Report Request Date 2/28/2017
T1D NO
TypeCount
Invoices 2
Progress Reports 2
Data Submission


Invoices
UrlCBU IDExternal IDInstitutionDateDirectIndirectInvoiceBalancePDF
  View  15GHSU251725034-75University of North Dakota2/27/2017$56,163.88$21,803.41$77,967.29$2,736.81View PDF
  View  15GHSU251725034-75University of North Dakota10/12/2016$6,354.60$2,478.30$8,832.90$2,736.81View PDF
Click here to cancel and return to funding program application

*Author:
*SubContract:
*Select File:

Click browse and select the file to upload.
(Please upload ONLY TXT, Image Files (not histolgy), PDF, XLS, XLSX, DOC, or DOCX files.)